Activation of c-Myc confers resistance to venetoclax via inhibition of Bim in t(8;21)-positive acute myeloid leukemia.

Venclexta (venetoclax) - Roche, AbbVie

Synribo (omacetaxine mepesuccinate) - Teva

azacitidine - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42277819

Baohong Ping; Dan Xu; Dandan Chen; Guopan Yu; Li Xuan; Qifa Liu; Zhao Yin; Zurong Yao

Jun 13, 2026